Introduction
Drug resistant epilepsy with mesial temporal sclerosis (MTS) has previously been reported as a late complication of haematological malignancies, mainly acute lymphoblastic leukaemia (ALL) and lymphoma with or without stem cell transplantation (SCT). [1,2] Most cases had no prior central nervous system inflammation or infection. It has been suggested that brain irradiation or intrathecal use of cytosine or methotrexate were possible causes.
[1] Here we report two cases of MTS in survivors of childhood acute myeloid leukaemia (AML) who had also received SCT, and review the literature of the reported cases of late onset drug resistant epilepsy with MTS in childhood haematological malignancies.
Material and methods
We reviewed two patients with history of AML having received SCT who developed medically resistant epilepsies several years after completing treatment. Both developed MTS and required epilepsy surgery to become seizure free. Literature review was performed through OVID/EMBASE using the keywords leukaemia, haematological cancers, mesial temporal sclerosis, childhood, epilepsy and seizure.
Articles published in English from 1990 to 2016 with MTS as a late complication for haematological cancers were identified and reviewed.
Results

Case Summaries
Patient 1
A 24-year-old lady initially presented to our hospital with pallor at age six in 1997.
She was diagnosed with AML and was treated with Hong Kong Paediatric There was good engraftment and subsequent recovery. Another six doses of triple intrathecal chemotherapy were given during the post-transplantation period as central 
Literature review
There were six articles with twelve patients reported. All patients suffered from epilepsy as a late complication of acute leukaemia in childhood. They suffered from
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6 leukaemia before 18 years of age. The onset of epilepsy was at least two years after chemotherapy. Of the twelve patients, eight patients had MTS or corresponding MRI findings. Epilepsy surgery was performed and had rendered them seizure free.
Discussion
Seizures are seen in 8-13% of patients in ALL. [8] Most seizures occur during the induction and consolidation phases. For AML, there is no data on seizure incidence in the current literature. However, it is believed to be much lower than in ALL. These 
Mesial temporal sclerosis as late complication in AML survivors
Prince of Wales Hospital is a tertiary hospital who has a specialized Children's Cancer Centre. We receive referrals from the territory for management of oncology to have AML at age 12 with no CNS involvement. He developed early complex partial seizures two months after bone marrow transplantation associated with high serum cyclosporin level (three times the upper limit). Initial MRI brain was normal.
He had second seizure five months later and gradually became more frequent with seizures up to two to three times per month. Repeated MRI brain (Two and a half year after initial study) showed left MTS.
Initial precipitant injury for mesial temporal sclerosis
MTS develops several years after an initial precipitant injury (IPI), leading to hippocampal lesions that becomes the epileptogenic zone. Common IPIs identified are 
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10 Similar postulation was also described by Fasano et al in 2008 [1] and Yoshida et al in 2013 [7] . Yet there is not data available regarding the association of dose of intrathecal medication use and seizure activity.
Early surgical evaluation
Most seizures in the reported cases were resistant to medical treatment. Together with the two cases that we reported, ten out of fourteen (71.4%) had temporal lobe epilepsy and MTS as suggested on subsequent MRIs and interictal/ictal EEGs. Six out of ten (60%) had epileptic surgery performed and all achieved seizure freedom. Therefore, early referral for epilepsy surgery workup would be beneficial. Early epilepsy surgery should be considered if the seizures are drug resistant.
Conclusion
MTS is a potential late complication of childhood leukaemia, for both ALL and AML.
Increased vigilance for epilepsy in survivors of childhood leukaemia is required.
Exact mechanisms are to be further investigated. These seizures are usually drug resistant and early surgical evaluation is warranted. 
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